Biomarkers in GIST: Partly ready for prime-time use

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Gastrointestinal stromal tumors, or GISTs, are now among the most treatable of solid malignancies. Assessing actual tumor response remains challenging; however, in this issue of Clinical Cancer Research, two articles discuss biomarkers potentially helpful in predicting response or other long-term benefits with standard tyrosine kinase therapy use.

Original languageEnglish (US)
Pages (from-to)5603-5605
Number of pages3
JournalClinical Cancer Research
Issue number18
StatePublished - Sep 15 2009
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Biomarkers in GIST: Partly ready for prime-time use'. Together they form a unique fingerprint.

Cite this